Hexima puts up its defensins

By Dylan Bushell-Embling
Thursday, 31 July, 2008

Agbiotech company Hexima [ASX: HXL] has concluded a set of trials of its defensin-based technology in cotton crops.

The trials tested the company's genetically modified strains against two common fungal diseases, verticillium wilt and fusarium wilt.

Both crops demonstrated increased yield, and the modified plants in the fusarium trial showed increased survival rates.

A third, healthy, crop was also modified with defensin to test the effect of the technology on healthy plants. The crop showed no adverse effects.

Defensins are small peptides, analogues of which are also found in humans and other animals, which help destroy bacteria and fungi. Some are also thought to have insecticidal activity.

Related News

Novel antibiotic activates 'suicide' mechanism in superbug

Researchers have discovered a new class of antibiotic that selectively targets Neisseria...

Modifications in the placenta linked to psychiatric disorders

Schizophrenia, bipolar disorder and major depression disorder are the neuropsychiatric disorders...

ADHD may be linked with an increased risk of dementia

An adult brain affected by attention deficit hyperactivity disorder (ADHD) presents modifications...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd